Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...

Let’s start with a brief overview and history of the company. Dr. Marques: Of course. Pasithea Therapeutics is a company that has been founded with the objective to develop novel therapies, or best-in ...

So, it’s been a few years since you last spoke with The Wall Street Transcript. Let’s start with a refresher about the company and its history and how it’s evolved over the years. Mr. Groesbeck: I’ll ...

Let’s start with a brief history of the company and its focus on accessories for cannabis. Ms. Sher: Sure. So Greenlane is the leading global omnichannel platform for the development and distribution ...

Please introduce your firm, your role, and what you cover in terms of the psychedelics market. Mr. Trucchio: I work at H.C. Wainwright, an investment bank headquartered in New York, as a senior health ...

Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF) Ahmad Doroudian Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF) Robert Beasley Interview with the CEO: Greenlane Holdings ...

Let’s start with a brief overview of the company, including some major milestones. Mr. Beasley: Cansortium is a publicly traded company, which is a Canadian registered entity on the Ontario Exchange.

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.